See other companies on Welcome to the Jungle
Alira Health
Patient-centric advisory firm
- 501-1000 employees
- Healthcare
- B2B
- Market research
- Data Analysis
- Framingham, MA
Jump to section
Company mission
To humanize healthcare by helping healthcare and life sciences organizations innovate and grow
6% employee growth in 12 months
Our take
The healthcare industry has been undergoing digitization in recent years. Alira Health operates in tandem with this by working with healthcare and life sciences organizations that need support across their entire solutions lifecycle. From market research to end-to-end product development, the company complements clients’ expertise with a full spectrum of services and technology-powered consulting.
The acquisition of Chamow and Associates, a top biopharmaceutical consultancy, in early 2021 allowed Alira to offer further regulatory and product development offerings. This has granted the company the ability to offer full support to pharma companies.
Renewed funding has also paved the way for expanded development, bolstered further by the renewal of the 21st Century Cures Act in 2022. This legislation helps patients gain more control and freedom over their data and eases the burdens of drug and medical device developers. These 2022 breakthroughs will allow Alira Health to develop and explore new opportunities to actively engage patients, healthcare providers, payers, and suppliers.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Professional development and continuing education
- Global connection and travel
- Supported work life balance
- Access to dynamic projects and clients
Company values
- Integrity
- Service
- Quality
- Leadership
- Achievement
Funding (last 2 of 3 rounds)
Jan 2023
$58m
LATE VC
Jan 2022
$40m
LATE VC
Total funding: $133m
Leadership
Gabriele Brambilla
(CEO)Previously worked at Alira Health as a Managing Director. Currently a board member at numerous firms including WoundForce, enlightenVue, and Computational Life. Chairman at MetroWest Life Sciences Network.